13:19 EDT Capricor Therapeutics (CAPR) trading resumes
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor Therapeutics trading halted, volatility trading pause
- Capricor Therapeutics announces four-year data from HOPE-2 OLE study
- FDA’s Nicole Verdun placed on administrative leave, STAT reports
- Capricor Therapeutics announces ODD to Deramiocel
- Capricor treatment of Becker muscular dystrophy granted orphan designation